Kun Lin Technology Co., Ltd. is an international company established by Zhejiang Kunlin Business & Trade Co., Ltd. in 2017 to facilitate import of medical equipment and better serve the Chinese market. Headquarters in Hangzhou, Zhejiang, we and our affiliated companies have our management level made up of graduates from professional medicine schools and with more than one decade of working experiences in China’s medical care market. Our top-level partners consist of not only stockholders with independent product operation experiences in Mainland China for more than one decade, but also those having served as CTO of Mainland China, Sales Director of Mainland China, Regional Sales Manager and so on in renowned pharmaceutical enterprises both in Mainland China and internationally such as Scaccia Co., Ltd. from Sweden, Medtronic Cardiac Business Unit, GMED, a subsidiary of Johnson & Johnson, OMS China, Lepu Medical Government Affairs Department, etc. We have a wide range of products, covering minimally invasive surgery, gastroenterology department, anesthesia department, etc. Currently, we have established the Sales Department, the Market Department, the Government Affairs Department and the Foreign Trade Department. Our offices have been set up in Beijing, Sichuan and Ningbo. Our workforce totals at around 30. Personnel of the Government Affairs Department are located in Beijing, having independently finished registration, alteration and update of the registration certificate of multiple products in China. In particularly, our Sales Department and Market Department have fully independent ability and network to bid, develop, sell and conduct academic cooperation in China. So far, we have developed more than 100 agents and corporate partners. More than 50% of hospitals in China have business connection with us. Among them, Sinopharm Group Co., Ltd. and China Resources Pharmaceutical Group Limited are two of the largest pharmaceutical groups in China. To our honor, we have built in-depth partnership with them. Meanwhile, our academic cooperation has been extended to multiple large-scale domestic grade-III, class-A hospitals. Now, we hold and are negotiating about exclusive agency of several imported medical equipment in Mainland China.